Wyoming's state-issued stablecoin, FRNT, has integrated Chainlink Proof of Reserve to provide automated, on-chain verification of its asset backing. This move enhances transparency by allowing third parties to independently confirm that the token's reserves match its circulating supply, which remains below 1 million units, indicating an early or controlled rollout. The adoption of this technology aims to build trust and credibility in the stablecoin by ensuring reserve transparency before wider distribution. This step aligns with Wyoming's broader efforts to establish robust digital asset infrastructure amid evolving U.S. regulatory landscapes for digital banking and stablecoins.
Hutchison China MediTech Limited (HCM) received a Buy rating upgrade from Daiwa with a new price target of $18.50 following a major licensing deal with GSK. The agreement grants GSK exclusive rights to commercialize HCM's experimental cancer therapy ...
Duluth Holdings reported a strong Q2 earnings per share (EPS) of $0.50, far exceeding the consensus estimate of -$0.01, largely due to $0.44 per share from tariff refunds. Revenue reached $121.39 million, beating estimates but declining from the prev...
Estée Lauder Companies recently appointed new brand leaders, signaling strategic shifts in its competitive beauty market. An insider executive sold 7,766 shares worth over $802,000, leaving no remaining holdings. The company shows a high P/E ratio of...
HUTCHMED's shares surged 17.77% after announcing a major licensing deal with GSK for its preclinical cancer drug HMPL-A830. GSK gets exclusive rights outside Greater China, paying $110 million upfront plus up to $1.295 billion in milestone payments. ...
Genesco reported second-quarter earnings that surpassed analyst expectations, with an EPS loss of $0.83 versus the estimated loss of $1.37 per share. Although revenue fell 3% year-over-year to $529.86 million, the company improved its adjusted gross ...
